Research indicates low-carb diets may enhance appetite regulation and reduce food cues in women with lipedema, offering a ...

Rural women are pivotal in addressing India's obesity and metabolic disorders through community action and public-private ...

India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on semaglutide signal major shifts in medical access, affordability and ...

A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

A study reveals high levels of internalised weight bias among obesity patients, significantly impacting their mental health ...

Women with obesity who discontinued GLP-1s were at increased risk for multiple adverse pregnancy outcomes than those who had never been on the drugs.

Children born to mothers with prepregnancy obesity face a higher risk for neurodevelopmental disorders (ie, epilepsy).

Treating risk factors that emerge during midlife can reduce a woman’s chances of developing diabetes, heart disease, and ...

A majority of the women in Singapore who have Polycystic Ovary Syndrome have a milder form of it. Read more at ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

A study by researchers at the Federal University of São Carlos (UFSCar) in Brazil, in partnership with University College ...